Literature DB >> 26817529

The responses of immune cells to iron oxide nanoparticles.

Yaolin Xu1, Jennifer A Sherwood1, Kimberly H Lackey2, Ying Qin3, Yuping Bao1.   

Abstract

Immune cells play an important role in recognizing and removing foreign objects, such as nanoparticles. Among various parameters, surface coatings of nanoparticles are the first contact with biological system, which critically affect nanoparticle interactions. Here, surface coating effects on nanoparticle cellular uptake, toxicity and ability to trigger immune response were evaluated on a human monocyte cell line using iron oxide nanoparticles. The cells were treated with nanoparticles of three types of coatings (negatively charged polyacrylic acid, positively charged polyethylenimine and neutral polyethylene glycol). The cells were treated at various nanoparticle concentrations (5, 10, 20, 30, 50 μg ml(-1) or 2, 4, 8, 12, 20 μg cm(-2)) with 6 h incubation or treated at a nanoparticle concentration of 50 μg ml(-1) (20 μg cm(-2)) at different incubation times (6, 12, 24, 48 or 72 h). Cell viability over 80% was observed for all nanoparticle treatment experiments, regardless of surface coatings, nanoparticle concentrations and incubation times. The much lower cell viability for cells treated with free ligands (e.g. ~10% for polyethylenimine) suggested that the surface coatings were tightly attached to the nanoparticle surfaces. The immune responses of cells to nanoparticles were evaluated by quantifying the expression of toll-like receptor 2 and tumor necrosis factor-α. The expression of tumor necrosis factor-α and toll-like receptor 2 were not significant in any case of the surface coatings, nanoparticle concentrations and incubation times. These results provide useful information to select nanoparticle surface coatings for biological and biomedical applications.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cellular uptake and toxicity; immune response; iron oxide nanoparticles; monocytes; surface-dependent effects

Mesh:

Substances:

Year:  2016        PMID: 26817529     DOI: 10.1002/jat.3282

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  7 in total

Review 1.  Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.

Authors:  Ankit Shah; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2018-02-02       Impact factor: 5.307

Review 2.  Effects of engineered nanoparticles on the innate immune system.

Authors:  Yuanchang Liu; Joseph Hardie; Xianzhi Zhang; Vincent M Rotello
Journal:  Semin Immunol       Date:  2017-10-04       Impact factor: 11.130

3.  Surface modification affect the biodistribution and toxicity characteristics of iron oxide magnetic nanoparticles in rats.

Authors:  Pengfei Yang; Hengyi Xu; Zhihong Zhang; Lin Yang; Huijuan Kuang; Zoraida P Aguilar
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

4.  Nutritional perspectives for the prevention and mitigation of COVID-19.

Authors:  Saeed Akhtar; Jai K Das; Tariq Ismail; Muqeet Wahid; Wisha Saeed; Zulfiqar A Bhutta
Journal:  Nutr Rev       Date:  2021-02-11       Impact factor: 7.110

5.  Genotoxicity of aluminium oxide, iron oxide, and copper nanoparticles in mouse bone marrow cells.

Authors:  Rakhshinda Sadiq; Qaiser Mahmood Khan; Ameena Mobeen; Asma Shah
Journal:  Arh Hig Rada Toksikol       Date:  2021-12-30       Impact factor: 1.948

6.  Synthesis of Distinct Iron Oxide Nanomaterial Shapes Using Lyotropic Liquid Crystal Solvents.

Authors:  Seyyed Muhammad Salili; Matthew Worden; Ahlam Nemati; Donald W Miller; Torsten Hegmann
Journal:  Nanomaterials (Basel)       Date:  2017-08-02       Impact factor: 5.076

7.  Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions.

Authors:  Laura Sanz-Ortega; José M Rojas; Yadileiny Portilla; Sonia Pérez-Yagüe; Domingo F Barber
Journal:  Front Immunol       Date:  2019-08-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.